866-997-4948 (US-Canada Toll Free)

Radio Frequency Identification (RFID) In Healthcare Industry - Global Market Size, Share, Growth, Analysis And Forecast, 2012 - 2018

Published By :

Transparency

Published Date : 2012-10-15

Category :

Healthcare

No. of Pages : 67

Product Synopsis

This report helps to identify factors, which will be the driving force behind the global RFID in healthcare industry and sub-markets in the next six years. The report provides extensive analysis of the RFID industry, current market trends, industry drivers and challenges for better understanding of the global RFID in healthcare industry. The report has segregated the RFID industry in terms of technology, application and geography. Annual estimates and forecasts are provided for the period 2011 through 2018 in terms of in USD million. The report helps in providing a comprehensive overview for Market forces that are driving and restraining the growth of the industry Opportunities for the application segments and geographies covered Up-to-date... Read More

Table Of Content

TABLE OF CONTENTS

CHAPTER 1 INTRODUCTION
1.1 REPORT DESCRIPTION
1.2 METHODOLOGY

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 GLOBAL RFID MARKET IN HEALTHCARE
3.1 MARKET OVERVIEW
3.2 MARKET ESTIMATE AND FORECAST FOR RFID IN HEALTHCARE
3.3 MARKET SHARE BY REGION
3.4 MARKET SHARE BY TECHNOLOGY
3.5 MARKET DYNAMICS
3.5.1 KEY MARKET DRIVERS
3.5.1.1 RFID enables Cure for drug Counterfeiting in healthcare
3.5.1.2 Improved tracking and accountability will improve reliability in drug approval process
3.5.1.3 Improved operational efficiency with RFID drives the market
3.5.1.4 Growing RFID application in healthcare
3.5.1.5 Government initiative will drive the RFID market in healthcare
3.5.2 RESTRAINTS
3.5.2.1 Lack of Standardization
3.5.2.2 Price as a concern
3.6 REGULATORY STATUS FOR USING RFID
3.7 PORTER’S FIVE FORCE ANALYSIS
3.7.1 BARGAINING POWER OF SUPPLIER
3.7.1 BARGAINING POWER OF BUYER
3.7.2 RIVALRY AMONG EXISTING COMPETITORS
3.7.3 THREAT OF NEW ENTRANTS
3.7.4 THREAT OF SUBSTITUTE PRODUCTS

CHAPTER 4 RFID MARKET BY TECHNOLOGY
4.1 MARKET OVERVIEW
4.2 RFID MARKET SIZE AND FORECAST BY TECHNOLOGY
4.3 MARKET ATTRACTIVENESS ANALYSIS FOR RFID TECHNOLOGY MARKET
4.4 TAGS MARKET
4.5 TAGS MARKET BY GEOGRAPHY
4.5.1 PASSIVE TAGS
4.5.1.1 Market Analysis, Size and Forecast
4.5.2 ACTIVE TAGS MARKET
4.5.2.1 Market Analysis, Size and Forecast
4.6 READERS MARKET
4.7 READERS MARKET BY GEOGRAPHY
4.7.1 MARKET ANALYSIS, SIZE AND FORECAST
4.7.2 PASSIVE READERS MARKET
4.7.2.1 Market Analysis, Size and Forecast
4.7.3 ACTIVE READERS MARKET
4.7.3.1 Market Analysis, Size and Forecast
4.7.4 HYBRID READERS MARKET
4.7.4.1 Market Analysis, Size and Forecast
4.8 MIDDLEWARE
4.8.1 MARKET ANALYSIS, SIZE AND FORECAST

CHAPTER 5 RFID MARKET IN HEALTHCARE BY APPLICATION
5.1 MARKET OVERVIEW
5.2 RFID MARKET APPLICATION MARKET SIZE AND FORECAST
5.3 RFID APPLIED TO OBJECT: MEDICATION AND EQUIPMENT TRACKING
5.3.1 TRACKING MEDICAL HOSPITAL EQUIPMENT MARKET 
5.3.1.1 MARKET ANALYSIS, SIZE AND FORECAST
5.3.2 TRACKING MEDICATION FROM PHARMACY TO PATIENT MARKET 
5.3.2.1 MARKET ANALYSIS, SIZE AND FORECAST
5.4 RFID APPLIED TO OBJECT: BLOOD TRANSFER MONITORING (SERVICE SUPPORT) MARKET 
5.4.1 MARKET ANALYSIS, SIZE AND FORECAST
5.5 PEOPLE IDENTIFICATION AND LOCALIZATION MARKET 
5.5.1 MARKET ANALYSIS, SIZE AND FORECAST
5.6 MARKET ATTRACTIVENESS RFID APPLICATION MARKET 

CHAPTER 6 RFID MARKET BY GEOGRAPHY
6.1 MARKET OVERVIEW
6.2 RFID MAREKT BY GEOGRAPHICAL REGIONS
6.3 NORTH AMERICA 
6.3.1 MARKET ANALYSIS, SIZE AND FORECAST
6.4 EUROPE 
6.4.1 MARKET ANALYSIS, SIZE AND FORECAST
6.5 ASIA PACIFIC 
6.5.1 MARKET ANALYSIS, SIZE AND FORECAST
6.6 ROW 
6.6.1 MARKET ANALYSIS, SIZE AND FORECAST

CHAPTER 7 COMPETITIVE LANDSCAPE
7.1 MARKET SHARE ANALYSIS
7.1 MARKET SHARE BY KEY PLAYERS

CHAPTER 8 COMPANY PROFILES
8.1 3M
8.1.1 COMPANY OVERVIEW
8.1.2 FINANCIAL OVERVIEW
8.1.1 COMPANY STRATEGY
8.1.2 RECENT DEVELOPMENTS
8.2 ATMEL
8.2.1 COMPANY OVERVIEW
8.2.2 FINANCIAL OVERVIEW
8.2.1 COMPANY STRATEGY
8.2.2 RECENT DEVELOPMENTS
8.3 ACCENTURE
8.3.1 COMPANY OVERVIEW
8.3.2 FINANCIAL OVERVIEW
8.3.1 COMPANY STRATEGY
8.3.2 RECENT DEVELOPMENTS
8.4 HITACHI
8.4.1 COMPANY OVERVIEW
8.4.2 FINANCIAL OVERVIEW
8.4.1 COMPANY STRATEGY
8.4.2 RECENT DEVELOPMENTS
8.5 IBM
8.5.1 COMPANY OVERVIEW
8.5.2 COMPANY STRATEGY
8.5.3 FINANCIAL OVERVIEW
8.5.4 RECENT DEVELOPMENTS
8.6 AEROSCOUT INC.
8.6.1 COMPANY OVERVIEW
8.6.2 RECENT DEVELOPMENTS
8.7 SIEMENS HEALTHCARE
8.7.1 MARKET OVERVIEW
8.7.2 FINANCIAL PERFORMANCE
8.7.3 BUSINESS DESCRIPTION
8.7.4 SWOT ANALYSIS

List of Tables

TABLE 1 LIST OF SFFC MEDICINES 
TABLE 2 GLOBAL RFID MARKET IN HEALTHCARE REVENUE, BY TECHNOLOGY, 2012 - 2018 (USD MILLION) 
TABLE 3 GLOBAL RFID TAGS IN HEALTHCARE MARKET REVENUE, 2012 - 2018 (USD MILLION) 
TABLE 4 RFID TAGS IN HEALTHCARE MARKET REVENUE, BY GEOGRAPHY, 2012 - 2018 (USD MILLION) 
TABLE 5 PASSIVE TAGS IN HEALTHCARE MARKET REVENUE, BY GEOGRAPHY, 2012 - 2018 (USD MILLION) 
TABLE 6 ACTIVE TAGS IN HEALTHCARE MARKET REVENUE, BY GEOGRAPHY, 2012 - 2018 (USD MILLION) 
TABLE 7 GLOBAL RFID READERS IN HEALTHCARE MARKET REVENUE, 2012 - 2018 (USD MILLION) 
TABLE 8 RFID READERS IN HEALTHCARE MARKET REVENUE, BY GEOGRAPHY, 2012 - 2018 (USD MILLION) 
TABLE 9 RFID PASSIVE READERS IN HEALTHCARE MARKET REVENUE, BY GEOGRAPHY, 2012 - 2018 (USD MILLION) 
TABLE 10 RFID ACTIVE READERS IN HEALTHCARE MARKET REVENUE, BY GEOGRAPHY, 2012 - 2018 (USD MILLION) 
TABLE 11 RFID HYBRID READERS IN HEALTHCARE MARKET REVENUE, BY GEOGRAPHY, 2012 - 2018 (USD MILLION) 
TABLE 12 RFID MIDDLEWARE IN HEALTHCARE MARKET REVENUE, BY GEOGRAPHY, 2012 - 2018 (USD MILLION) 
TABLE 13 GLOBAL RFID IN HEALTHCARE APPLICATION MARKET REVENUE, BY GEOGRAPHY, 2012 - 2018 (USD MILLION) 
TABLE 14 TRACKING MEDICAL HOSPITAL EQUIPMENT APPLICATION MARKET REVENUE, BY GEOGRAPHY, 2012 - 2018 (USD MILLION) 
TABLE 15 TRACKING MEDICATION FROM PHARMACY TO PATIENT MARKET REVENUE, BY GEOGRAPHY, 2012 - 2018 (USD MILLION) 
TABLE 16 BLOOD TRANSFER MONITORING MARKET REVENUE, BY GEOGRAPHY, 2012 - 2018 (USD MILLION) 
TABLE 17 PEOPLE IDENTIFICATION AND LOCALIZATION MARKET REVENUE, BY GEOGRAPHY, 2012 - 2018 (USD MILLION) 
TABLE 18 RFID IN HEALTHCARE MARKET REVENUE, BY GEOGRAPHY, 2012 - 2018 (USD MILLION) 

List of Figures

FIG. 1 MARKET SHARE BY TECHNOLOGICAL SEGMENT (%) 2018 ESTIMATE 
FIG. 2 MARKET ATTRACTIVENESS ANALYSIS FOR RFID TECHNOLOGY MARKET 
FIG. 3 RFID TAGS IN HEALTHCARE MARKET REVENUE, BY COUNTRY , 2012 - 2018, (USD MILLION) 
FIG. 4 RFID PASSIVE TAGS IN HEALTHCARE MARKET REVENUE, BY COUNTRY , 2012 - 2018, (USD MILLION) 
FIG. 5 RFID ACTIVE TAGS IN HEALTHCARE MARKET REVENUE, BY COUNTRY , 2012 - 2018, (USD MILLION) 
FIG. 6 RFID READERS IN HEALTHCARE MARKET REVENUE, BY COUNTRY , 2012 - 2018, (USD MILLION) 
FIG. 7 RFID PASSIVE READERS IN HEALTHCARE MARKET REVENUE, BY COUNTRY , 2012 - 2018, (USD MILLION) 
FIG. 8 RFID ACTIVE READERS IN HEALTHCARE MARKET REVENUE, BY COUNTRY , 2012 - 2018, (USD MILLION) 
FIG. 9 RFID HYBRID READERS IN HEALTHCARE MARKET REVENUE, BY COUNTRY , 2012 - 2018, (USD MILLION) 
FIG. 10 RFID MIDDLEWARE IN HEALTHCARE MARKET REVENUE, BY COUNTRY , 2012 - 2018, (USD MILLION) 
FIG. 11 TRACKING MEDICAL HOSPITAL EQUIPMENT MARKET REVENUE, BY COUNTRY , 2012 - 2018, (USD MILLION) 
FIG. 12 TRACKING MEDICATION FROM PHARMACY TO PATIENT MARKET REVENUE, BY COUNTRY , 2012 - 2018, (USD MILLION) 
FIG. 13 BLOOD TRANSFER MONITORING MARKET REVENUE, BY COUNTRY , 2012 - 2018, (USD MILLION) 
FIG. 14 PEOPLE IDENTIFICATION AND LOCALIZATION MARKET REVENUE, BY COUNTRY , 2012 - 2018, (USD MILLION) 
FIG. 15 MARKET ATTRACTIVENESS ANALYSIS FOR RFID APPLICATION MARKET 
FIG. 16 NORTH AMERICA RFID MARKET REVENUE, BY COUNTRY , 2012 - 2018, (USD MILLION) 
FIG. 17 EUROPE RFID MARKET REVENUE, BY COUNTRY , 2012 - 2018, (USD MILLION) 
FIG. 18 ASIA-PACIFIC & JAPAN RFID MARKET REVENUE, 2012 - 2018, (USD MILLION) 
FIG. 19 LATIN AMERICA & MEARFID MARKET REVENUE, 2012 - 2018, (USD MILLION) 
FIG. 20 MARKET SHARE OF MAJOR GLOBAL RFID IN HEALTHCARE MANUFACTURERS, 2011 (%) 

Make an enquiry before buying this Report

Please fill the enquiry form below.

Full Name * Message
Your Email *
Job Title
Phone No. * (Pls. Affix Country Code) Security Code *

Upcoming Reports

  • Poland: wire and wire products market

    By - Williams and Marshal Strategy

    This report presents a comprehensive overview of the wire and wire products market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the wire and wire products market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an...

  • Liquid Biofuels Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013 - 2019

    By - Transparency

    Biofuels are a class of fuels whose energy is derived biologically from carbon fixation. They are derived from various conversion procedures from solid biomass, liquid fuels and various gases. Liquid biofuels are produced from various oil-rich crops and are grown in many regions across the globe. With the growing demand for energy across the globe, the biofuels market is witnessing large amounts of investments to ensure a permanent source of clean energy. There has been a tremendous increase in the demand for biofuels since they are naturally derived and can replace non-renewable...

  • Non Small Cell Lung Cancer Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018

    By - Transparency

    Globally, the Non-Small-Cell Lung Cancer (NSCLC) drug market will increase from USD 4.3 billion in 2009 to USD 6.9 billion in 2019 and the market is growing with a CAGR of 4.84% during 2009 to 2019. The major markets in these segments are the United States, France, Germany, Italy, Spain, United Kingdom and Japan. The global top five global brands in NSCLC with the largest market share are Avastin, Tarceva, Alimta, Gemzar and Taxotere. For growth in the future there are drugs in the pipeline and in clinical trials at the phase 3 process development in the non small cell lung...